We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00447850
First Posted: March 15, 2007
Last Update Posted: September 21, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Instituto Valenciano de Infertilidad, IVI VALENCIA
March 13, 2007
March 15, 2007
September 21, 2009
April 2007
July 2009   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00447850 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization
Endometrial Gene Expression Profile in Controlled Ovarian Stimulation Cycles With Premature Luteinization
Previous studies have suggested that premature luteinization (PL)during controlled ovarian stimulation (COS) decreases the implantation rate due to a negative effect on the endometrium receptivity. This study aims to describe the impact on endometrial gene expression of PL in GnRH antagonist and GnRH agonist cycles.
Not Provided
Interventional
Not Provided
Not Provided
Premature Luteinization
Procedure: endometrial biopsy
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
Not Provided
July 2009
July 2009   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Oocyte donors
  • Age between 18-35 years old
  • BMI 18-29
  • NORMOGONADOTROPHICS
  • PROGESTERONE ≥ 1.2 ng/ml on hCG day

Exclusion Criteria:

  • PolyCystic Ovarian Syndrome (PCOS)
  • Endometriosis
Sexes Eligible for Study: Female
18 Years to 35 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Spain
 
 
NCT00447850
VLC-EL-1006- 307-2
Not Provided
Not Provided
Not Provided
Dr. Elena Labarta, Instituto Valenciano de Infertilidad
Instituto Valenciano de Infertilidad, IVI VALENCIA
Not Provided
Principal Investigator: Elena Labarta, MD Instituto Valenciano de la Infertilidad
Instituto Valenciano de Infertilidad, IVI VALENCIA
September 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP